Toba Pulp Lestari Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Toba Pulp Lestari Tbk trades at Rp590 (market cap 826.39B, 34.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Toba Pulp Lestari Tbk is far larger — about 5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 34.5K). Which is the better fit depends on your goals.
| INRU | OBAT | |
|---|---|---|
Market Cap | 826.39B | 166.01B |
Volume | 34.5K | 324K |
Lot | 345 | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Toba Pulp Lestari Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 329 dated April 26, 1983 of Misahardi Wilamarta, S.H., public notary in Jakarta.
Read more on INRU →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →